ePT--the Electronic Newsletter of Pharmaceutical Technology
President Bush signed HR 2764, making appropriations to the US Food and Drug Administration during FY 2008, which ends September 30, 2008.
Washington DC (Dec. 26)-President Bush signed HR 2764, making appropriations to the US Food and Drug Administration during FY 2008, which ends September 30, 2008. The Act allocates more than $1.7 billion to FDA, representing more than $145 million above the FY 2007 budget. Specifically, it allows:
The Act, however, bans FDA from using this funding for the agency’s Reagan–Udall Foundation, the private, independent nonprofit organization whose objective is to “advance FDA’s mission to modernize medical, veterinary, food, food ingredient, and cosmetic product development, accelerate innovation, and enhance product safety” and promotes FDA’s Critical Path Initiative. The US Congress mandated the foundation’s creation in the Food and Drug Administration Amendments Act, passed in September 2007.
Some members of Congress have expressed their concerns regarding the influence of FDA on the foundation. Representative Rosa DeLauro (D-CN), chairwoman of the subcommittee that funds FDA, stated “there is no framework to minimize the industry’s influence on the foundation” and could “endorse the approval of drugs based on lower standards.”
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.